Aurinia Pharmaceuticals (AUPH) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aurinia Pharmaceuticals (AUPH) Misses Q4 EPS by 2c

Aurinia Pharmaceuticals (AUPH) PT Raised to $11 at RBC Capital

March 20, 2019 6:29 AM EDT

RBC Capital analyst Douglas Miehm raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $11.00 (from $9.00) while maintaining a Outperform rating.

no surprises out of the resultsremains on track in its Ph. III lupus nephritis trialupdated model on positive IP developments for voclosporin... More